
IndraLab
Statements
sparser
"Inhibition of Kv10.1 by the potassium channel blocker astemizole, the specific anti-Kv10.1 antibody mAb56, or siRNA strongly increased apoptosis in primary AML cells and cell lines treated with chemotherapeutic agents commonly used in AML therapy, including etoposide, cytarabine, and doxorubicin [ xref ]."
reach
"A possible role of hEag1 in leukemia cell proliferation could be shown by growth and migration inhibition of the hEag1 expressing cell lines PLB-985, K562, UT-7 and HEL and primary clinical samples by the potassium channel blockers astemizole, imipramine, the hEag1 specific monoclonal antibody mAb56 and siRNA knockdown [XREF_BIBR]."